Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • A single PSA test taken at or before age 50 is a very strong predictor of advanced prostate cancer diagnosed up to 25 years later. This suggests the possibility of using an early PSA test to risk-stratify patients so that men at highest risk are the focus of the most intensive screening efforts.

publication date

  • February 15, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2275744

Digital Object Identifier (DOI)

  • 10.1186/1741-7015-6-6

PubMed ID

  • 18279502

Additional Document Info

start page

  • 6

volume

  • 6